insights_auto
Why is AGIO down 3,10%?
Dive Deeperchevron_right
AGIO:NASDAQ
Agios Pharmaceuticals Inc
28,76 USD
arrow_downward
-3,10%(-0,92) 1D
28,76 USD
0,00% (0,00)
bedtimeAfter hours
Closed: 19-ноя., 16:00:01 GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for AGIO...
Open
29,93 USD
High
30,35 USD
Low
28,71 USD
Mkt. cap
1,72 млд
Avg. vol.
1,18 млн
Volume
469,84 миң
52-wk high
44,07 USD
52-wk low
23,02 USD
EPS
-6,32 USD
Beta
0,66
Shares outstanding
59,81 млн
No. of employees
540
Open
29,93 USD
High
30,35 USD
Low
28,71 USD
Mkt. cap
1,72 млд
Avg. vol.
1,18 млн
Volume
469,84 миң
52-wk high
44,07 USD
52-wk low
23,02 USD
EPS
-6,32 USD
Beta
0,66
Shares outstanding
59,81 млн
No. of employees
540
News stories
From web sources and news partners
FXStreet
·
41 мүнөт мурун
Dow Jones Industrial Average falls over 1,000 points as Anthropic IPO dominates
Traders Union
·
37 мүнөт мурун
Gunjan Banerji: Only 38 S&P 500 stocks rose, fewest gainers since December 31, 2025
The Motley Fool
·
22 мүнөт мурун
Stock Market Today, Nov. 19: Dow Plunges 1,100 Points as the S&P 500 Suffers Its 6th Straight Day of Losses
Investing.com
·
33 мүнөт мурун
U.S. stocks lower at close of trade; Dow Jones Industrial Average down 2.19%
Profile
Agios Pharmaceuticals Inc. is a publicly trading American pharmaceutical company pioneering therapies for genetically defined diseases, with a near-term focus on developing therapies for hemolytic anemias. The company was founded in 2008 by Lewis Cantley, Tak Mak and Craig Thompson. Agios is a Delaware corporation headquartered in Cambridge, Massachusetts. The company tendered an initial public offering in July 2013. Wikipedia
About Agios Pharmaceuticals Inc